Deakin University
Browse

File(s) under permanent embargo

International randomized study of interferon vs STI571 (IRIS) 8-year follow-up: Sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib

journal contribution
posted on 2009-11-20, 00:00 authored by M Deininger, S O’Brien, F Guilhot, J Goldman, A Hochhaus, T Hughes, J Radich, A Hatfield, M Mone, J Filian, John Reynolds, I Gathmann, R Larson, B Druker
International randomized study of interferon vs STI571 (IRIS) 8-year follow-up: Sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib

History

Journal

Blood

Volume

114

Issue

22

Season

Abstract # 1126

Pagination

1 - 1

Publisher

American Society of Hematology

Location

Washington, D. C.

ISSN

0006-4971

eISSN

1528-0020

Language

eng

Notes

Alternative source title : Blood (ASH Annual Meeting Abstracts); Chronic Myeloid Leukemia - Therapy Poster I presented at American Society of Hematology. Annual Meeting (51st : 2009 : New Orleans, Louisiana) held from 5 - 8 Dec. 2009

Publication classification

C2.1 Other contribution to refereed journal

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    international randomized study (IRIS)interferonSTI5718-year follow-upsustained survivallow risk for progressionpatientsnewly diagnosedchronic myeloid leukemia in chronic phase (CML-CP)imatinib

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC